|
|
Article: Provectus Pharmaceuticals, Inc. (OTCBB:PVCT) just released some important news.
- Article from:
- M2 Presswire
- Article date:
- July 7, 2008
CopyrightCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-7 July 2008-Stockwire.com: Provectus Pharmaceuticals, Inc. (OTCBB:PVCT) just released some important news.(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:07072008
Provectus Pharmaceuticals, Inc. (OTCBB:PVCT) just announced First Twenty-Five Percent of Subjects in Phase 2 Melanoma Clinical Trial Treated.
A dedicated Chat Room for Provectus Pharmaceuticals, Inc., has been created at STOCKWIRE.com to discuss this news event.
Visit the following link to begin chatting with your fellow shareholders: http://www.stockwire.com/chat
----------------------------------------------------------
Provectus Pharmaceutical, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Provectus Pharmaceuticals Completes Sale of Equity ...
PR Newswire;
December 9, 2004 ;
700+ words
...Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT) announced ... used for general corporate purposes. About Provectus Pharmaceuticals, Inc. Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT - News) is ...
|
|